Skip to content
CompanySight
Company No. 06751116 · Incorporated 17 Nov 2008

Achieve Pharma UK Limited

Registered name: ACHIEVE PHARMA UK LIMITED

Part of Achieve Life Sciences, Inc. group

Achieve Pharma UK Limited made £2.1m revenue and a £535k loss in the year to 31 Dec 2023. read from filing text

Achieve Pharma UK Limited’s revenue grew 78% to £2.1m in the year to 31 Dec 2023, with a loss of £535k and 5 employees. The company is classified under “other research and experimental development on natural sciences and engineering” and is based in Henley-on-Thames; we hold 2 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 72190Other research and experimental development on natural sciences and engineering
Status
Active
Location
Henley-on-Thames, South East
Age
17 yrs · since 2008
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The immediate and ultimate parent Company is Achieve Life Sciences Inc. a Company registered in the United States of America, 520 Pike Street,”

Latest accounts · year to 31 Dec 2023

Key figures

Small teamCapital-light
Revenue
£2.1m
Growth ▲78.1%
Profit
−£535k
Growth —
Profit margin
−25.6%
 
Employees
5
Change ▲25%
Profit / employee
−£107k
Revenue/employee £417k
Profitable streak
0yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202231 Dec 2023
DisclosureFull P&Lread from filing textFull P&Lread from filing text
Profit & loss
Revenue (turnover)£1.2m£2.1m
Profit before tax−£89.2k−£535k
Profit after tax−£89.2k−£535k
Profit (best available)−£89.2k−£535k
Employees (average)45
Ratios
Profit margin−7.6%−25.6%
Revenue per employee£293k£417k
Profit per employee−£22.3k−£107k
Growth (year on year)
Revenue growth—▲78.1%
Headcount growth—▲25%
Balance sheet — indirect signals, not revenue
Cash at bank£101k£159k
Net assets£486k−£48.4k
Fixed assets£2k£5.3k
Current assets£1.1m£823k
Debtors£969k£663k
SourceFullAccounts · bulk data Sep 2024FullAccounts · bulk data Sep 2024
Derived from the latest filing

How the business works

Profit margin
−25.6%
Profit ÷ revenue.
Gross margin
—
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£417k
Revenue ÷ average employees.
Profit per employee
−£107k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
0.3%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
31.8%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▼110%
Now −£48.4k
Cash at bank
▲58%
Now £159k
Headcount
▲25%
Now 5
Deferred income
—
Now —
Fixed assets
▲162%
Now £5.3k
Corporate ownership

Group structure

Ownership chain

  1. Achieve Life Sciences, Inc. (registered outside the UK register)ultimate parent75–100%
  2. Achieve Pharma UK Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Dec 2023 (profit −£535k), from the Companies House accounts bulk data published Sep 2024. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.